Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Bioconjug Chem. 2009 Dec;20(12):2342–2347. doi: 10.1021/bc900361g

Figure 4.

Figure 4

Biodistribution data for 18F-FB-2.5D in nude mice bearing subcutaneous U87MG human tumor xenografts. Data are expressed as the percentage administered activity (injected dose) per gram of tissue (%ID/g) after intravenous injection of 370 kBq (10 μCi) 18F-FB-2.5D at 0.5 h p.i. with or without co-injection of 330 μg of c(RGDyK) (n = 3 for each group). Significant inhibition of U87MG tumor uptake (P < 0.05) was observed upon co-injection of this blocking agent.